Abstract:BackgroundTomatidine (TO) is a plant steroidal alkaloid that possesses an antibacterial activity against the small colony variants (SCVs) of Staphylococcus aureus. We report here the spectrum of activity of TO against other species of the Bacillales and the improved antibacterial activity of a chemically-modified TO derivative (FC04–100) against Listeria monocytogenes and antibiotic multi-resistant S. aureus (MRSA), two notoriously difficult-to-kill microorganisms.MethodsBacillus and Listeria SCVs were isolate… Show more
“…The mutant descriptions and MICs of TO, FC04-100 stereoisomers (FcM, FC04-100 major stereoisomer; Fcm, FC04-100 minor stereoisomer), and gentamicin are reported in Table 1. Note that we previously reported the MICs of the FC04-100 mixture of stereoisomers to be 8 to 16 and 0.5 to 2 g/ml for prototypic S. aureus and SCVs, respectively (13,37). Table 1 shows that FcM is the most potent component of the FC04-100 mixture.…”
Section: Resultsmentioning
confidence: 85%
“…Like bedaquiline, which is highly selective for the mycobacterial ATP synthase (9,10), TO selectively targets species of the Bacillales, namely, Staphylococcus, Listeria, and Bacillus spp. (11)(12)(13). Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) are often associated with recurrent and difficult-to-treat hospital-or community-acquired infections (14,15) and are among the bacterial threats identified by the CDC that require immediate attention (16).…”
mentioning
confidence: 99%
“…Our laboratory extensively documented the very potent (in the nanomolar range) and selective antibacterial activities of TO against SCVs of Staphylococcus, Bacillus, and Listeria spp. (11)(12)(13)37). We also investigated several structural analogs of TO in order to better understand its structure-activity relationship (37) and identified a promising TO derivative possessing a diamino group replacing the 3-hydroxyl group of TO (FC04-100) ( Fig.…”
mentioning
confidence: 99%
“…1). In addition to its anti-SCV activity, FC04-100 interestingly gained antibacterial activity against prototypical strains (13). The mode of action of TO and its analogs was clearly associated with the respiratory chain, but their molecular target was unknown until now.…”
Methicillin-resistant (MRSA) is a leading cause of deadly hospital-acquired infections. The discovery of anti- antibiotics and new classes of drugs not susceptible to the mechanisms of resistance shared among bacteria is imperative. We recently showed that tomatidine (TO), a steroidal alkaloid from solanaceous plants, possesses potent antibacterial activity against small-colony variants (SCVs), the notoriously persistent form of this bacterium that has been associated with recurrence of infections. Here, using genomic analysis of-generated TO-resistant strains to identify mutations in genes involved in resistance, we identified the bacterial ATP synthase as the cellular target. Sequence alignments were performed to highlight the modified sequences, and the structural consequences of the mutations were evaluated in structural models. Overexpression of the gene in SCVs or introducing the mutation found in the gene of one of the high-level TO-resistant mutants into the gene provided resistance to TO and further validated the identity of the cellular target. FC04-100, a TO derivative which also possesses activity against non-SCV strains, prevents high-level resistance development in prototypic strains and limits the level of resistance observed in SCVs. An ATP synthesis assay allowed the observation of a correlation between antibiotic potency and ATP synthase inhibition. The selectivity index (inhibition of ATP production by mitochondria versus that of bacterial ATP synthase) is estimated to be >10-fold for FC04-100.
“…The mutant descriptions and MICs of TO, FC04-100 stereoisomers (FcM, FC04-100 major stereoisomer; Fcm, FC04-100 minor stereoisomer), and gentamicin are reported in Table 1. Note that we previously reported the MICs of the FC04-100 mixture of stereoisomers to be 8 to 16 and 0.5 to 2 g/ml for prototypic S. aureus and SCVs, respectively (13,37). Table 1 shows that FcM is the most potent component of the FC04-100 mixture.…”
Section: Resultsmentioning
confidence: 85%
“…Like bedaquiline, which is highly selective for the mycobacterial ATP synthase (9,10), TO selectively targets species of the Bacillales, namely, Staphylococcus, Listeria, and Bacillus spp. (11)(12)(13). Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) are often associated with recurrent and difficult-to-treat hospital-or community-acquired infections (14,15) and are among the bacterial threats identified by the CDC that require immediate attention (16).…”
mentioning
confidence: 99%
“…Our laboratory extensively documented the very potent (in the nanomolar range) and selective antibacterial activities of TO against SCVs of Staphylococcus, Bacillus, and Listeria spp. (11)(12)(13)37). We also investigated several structural analogs of TO in order to better understand its structure-activity relationship (37) and identified a promising TO derivative possessing a diamino group replacing the 3-hydroxyl group of TO (FC04-100) ( Fig.…”
mentioning
confidence: 99%
“…1). In addition to its anti-SCV activity, FC04-100 interestingly gained antibacterial activity against prototypical strains (13). The mode of action of TO and its analogs was clearly associated with the respiratory chain, but their molecular target was unknown until now.…”
Methicillin-resistant (MRSA) is a leading cause of deadly hospital-acquired infections. The discovery of anti- antibiotics and new classes of drugs not susceptible to the mechanisms of resistance shared among bacteria is imperative. We recently showed that tomatidine (TO), a steroidal alkaloid from solanaceous plants, possesses potent antibacterial activity against small-colony variants (SCVs), the notoriously persistent form of this bacterium that has been associated with recurrence of infections. Here, using genomic analysis of-generated TO-resistant strains to identify mutations in genes involved in resistance, we identified the bacterial ATP synthase as the cellular target. Sequence alignments were performed to highlight the modified sequences, and the structural consequences of the mutations were evaluated in structural models. Overexpression of the gene in SCVs or introducing the mutation found in the gene of one of the high-level TO-resistant mutants into the gene provided resistance to TO and further validated the identity of the cellular target. FC04-100, a TO derivative which also possesses activity against non-SCV strains, prevents high-level resistance development in prototypic strains and limits the level of resistance observed in SCVs. An ATP synthesis assay allowed the observation of a correlation between antibiotic potency and ATP synthase inhibition. The selectivity index (inhibition of ATP production by mitochondria versus that of bacterial ATP synthase) is estimated to be >10-fold for FC04-100.
“…Tomatidine is a steroidal alkaloid derived from the stem and leaves of unripe, green tomatoes. It has been described to exhibit a variety of health-beneficial biological activities, including anti-metastatic activity 14 , anti-inflammatory activity 15 , anti-microbial activity [16][17][18] , and was shown to have a protective effect against age-related muscle atrophy 19 . Tomatidine was also found to exhibit antiviral activity towards the plant viruses Sunnhemp Rosette and Tobacco mosaic virus 20 .…”
in recent decades, chikungunya virus (cHiKV) has re-emerged, leading to outbreaks of chikungunya fever in Africa, Asia and central and South America. the disease is characterized by a rapid onset febrile illness with (poly)arthralgia, myalgia, rashes, headaches and nausea. In 30 to 40% of the cases, CHIKV infection causes persistent (poly)arthralgia, lasting for months or even years after initial infection. Despite the drastic re-emergence and clinical impact there is no vaccine nor antiviral compound available to prevent or control cHiKV infection. Here, we evaluated the antiviral potential of tomatidine towards cHiKV infection. We demonstrate that tomatidine potently inhibits virus particle production of multiple CHIKV strains. Time-of-addition experiments in Huh7 cells revealed that tomatidine acts at a post-entry step of the virus replication cycle. furthermore, a marked decrease in the number of cHiKV-infected cells was seen, suggesting that tomatidine predominantly acts early in infection yet after virus attachment and cell entry. Antiviral activity was still detected at 24 hours post-infection, indicating that tomatidine controls multiple rounds of cHiKV replication. Solasodine and sarsasapogenin, two structural derivatives of tomatidine, also showed strong albeit less potent antiviral activity towards cHiKV. in conclusion, this study identifies tomatidine as a novel compound to combat CHIKV infection in vitro.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.